The board of the Hyderabad-based pharmaceutical company also recommended a final dividend of ₹30 per share for FY26. Previous Post FTSE index rejig: Tata Capital, Lenskart, Groww, Meesho among additions to global indices Next Post Defence, exports and platform companies among top market themes: Envision’s Nilesh Shah Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment
